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Editorial on the Research Topic
Role of Blood Cells in Inflammatory and Vascular Disorders
The vascular endothelium is regulated by a range of mediators produced by circulating blood cells.
This interplay is crucial to control vascular function together with inflammatory processes. Indeed,
injury or infections generate a cascade of events that stimulate leukocytes transmigration leading to
release of both pro- and antinflammatory molecules. One of the key steps in the pro-resolutive
response is associated with the limitation of neutrophil emigration into inflamed tissues, together with
an increase in their clearance. One of the pivotal players in this process is represented by galectin 1
(Gal-1), which can strongly inhibit neutrophil transmigration as well as facilitate neutrophils removal
(Law et al.) (Figure 1). In addition, Gal-1 is also able to modulate the number of macrophages and
levels of pro- and anti-inflammatory cytokines, thus controlling the outcome of the inflammatory
process, also involving IFN-b in this mechanism (Yaseen et al.). Extracellular vesicles (EV) also play a
central role in tempering vascular responses. These membrane-bound vesicles that facilitate are
released by different cell types, and their content reflects both the cell of origin and its activation status.
Recent studies also demonstrate that EV derived from platelets, leukocytes, and endothelial cells
control the interplay and interactions between leukocytes and platelets and between platelets and
endothelial cells (Oggero et al.) (Figure 1). Among circulating blood cells, platelets have a peculiar role
in vascular homeostasis and thrombosis and are an important source of purine nucleotides and
nucleosides. The imbalance of extracellular purine levels is associated with an increase of
cardiovascular risk, and the role of CD39 might be crucial to predict platelets’ reactivity and their
ability to control nucleotides’/nucleosides’ effects (Caiazzo et al.) (Figure 1). Interestingly,
cardiovascular diseases are strictly linked to several chronic inflammatory pathologies, including
asthma. This association relies on the actions of inflammatory mediators such as IL-4, IL-6, IL-9, IL-
17A, IL-33, and TNF-a that somehow affect endothelial function at different vascular levels, thus
generating vascular dysfunction leading to atherosclerosis (Gurgone et al.). Although there is a
growing body of evidence that highlights the importance of interactions between blood cells and
endothelium, there is still a need to further elucidate the mechanisms involved in terms of cell-cell
activation in the view of a possible therapeutic approach tackling inflammatory-based cardiovascular
diseases (IBCDs). Interestingly, apart from different molecules undergoing preclinical and clinical
studies, natural products could also provide an interesting source of therapeutic items. Indeed,in.org September 2020 | Volume 11 | Article 5857051
Brancaleone et al. Editorial: Role of Blood Cellsmolecules like ginkgolic acid (GA) could potentially target
multiple key enzymes involved in the biosynthesis of pro-
inflammatory mediators (Gerstmeier et al.) (Figure 1).
Therefore, a multi-target approach could limit the inflammatory
response at different levels, including vasculature and heart. These
two organs represent the main targets in several pathologies,
including diabetes, where cardiovascular complications represent
the main cause of death in diabetic patients. Intriguingly, the use of
isolated red blood cells (RBC) from diabetic patients with a
different degree of glycemic control seems to have an effect on
cardiovascular function in terms of post-ischemic recovery,
possibly associated to RBC-arginase (Mahdi et al.).
All findings reported in this collection contribute to shed new
light on the pathophysiological events driving vascular and
inflammatory diseases, events that occur at the interface between
blood cells and endothelium. We trust that this Research Topic
will underscore the need for furthering our understanding in theseFrontiers in Pharmacology | www.frontiersin.org 2fundamental mechanisms of disease, further stimulating the
interest of scientists working in diverse disciplines.
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comply with these terms.FIGURE 1 | Representation of interplay between blood cells and endothelium during vascular inflammation.September 2020 | Volume 11 | Article 585705
